Journal profile · ONCOLOGY-CHEMISTRY, MEDICINAL
Anti-Cancer Agents in Medicinal Chemistry
ISSN 1871-5206 · eISSN 1875-5992 · Bentham Science Publishers B.V. · U ARAB EMIRATES · Monthly · Founded 2006
Anti-Cancer Agents in Medicinal Chemistry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.58; subscription journal; median 71 days to acceptance (70 articles, last 24 months); community-reported acceptance: fairly easy; 166 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Anti-Cancer Agents in Medicinal Chemistry is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Synthesis and biological activity, Cancer Mechanisms and Therapy and Cancer therapeutics and mechanisms, together about 25.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Source: LetPub
Research area (LetPub): ONCOLOGY-CHEMISTRY, MEDICINAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Synthesis and biological activityChemistry13.9%
- Cancer Mechanisms and TherapyMedicine5.9%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology5.5%
- Cancer Research and TreatmentMedicine4.4%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.2%
- Metal complexes synthesis and propertiesMedicine4.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.1%
- Nanoparticle-Based Drug DeliveryMaterials Science4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.58LetPub ·
- CiteScore 2026-06
- 6.7LetPub ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 0.68LetPub ·
- h-index
- 82LetPub ·
- h-index
- 122OpenAlex ·
- i10-index
- 1,888OpenAlex ·
- 2-year mean citedness
- 2.08OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 3.83%LetPub ·
Volume
- Articles per year
- 178LetPub ·
Articles by year OpenAlex count · 3,792 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 159 | 7 | 33 |
| 2025 | 166 | 11 | 305 |
| 2024 | 134 | 8 | 615 |
| 2023 | 164 | 15 | 951 |
| 2022 | 240 | 9 | 2,114 |
| 2021 | 326 | 27 | 3,672 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
71 daysMedian, submission to acceptance · P25–P75 54 days – 96 days
- Acceptance to online
- median 188 days (70 articles)
- Submission to online
- median 259 days
- Sample
- 70 articles with submission and acceptance dates (395 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham Science Publishers B.V.
- Country or region
- U ARAB EMIRATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2006
- ISSN
- 1871-5206
- Electronic ISSN
- 1875-5992
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Anti-Cancer Agents in Medicinal Chemistry
What CAS zone is Anti-Cancer Agents in Medicinal Chemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Anti-Cancer Agents in Medicinal Chemistry is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Anti-Cancer Agents in Medicinal Chemistry?
The latest impact factor listed by LetPub is 2.58; CiteScore 6.7, h-index 122.
How long does peer review take at Anti-Cancer Agents in Medicinal Chemistry?
Based on the dates recorded on 70 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 54–96 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Anti-Cancer Agents in Medicinal Chemistry?
According to LetPub and DOAJ records, Anti-Cancer Agents in Medicinal Chemistry is indexed in SCIE and Scopus.
Is Anti-Cancer Agents in Medicinal Chemistry open access, and what is the APC?
Anti-Cancer Agents in Medicinal Chemistry is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .